Background 59
Introduction 83
In December 2019, an outbreak of pneumonia of unknown etiology was reported in Wuhan, 84
Hubei province, China. The Chinese Center for Disease Control and Prevention (CDC) isolated 85 the causative viral pathogen from throat swabs sample of the affected patients. The pathogen was 86 a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by 87 WHO and the disease caused by SARS-CoV-2 was termed as coronavirus disease 2019 88 (COVID-19). Up to February 18, 2020, 58097 laboratory-confirmed cases of COVID-19 and 1870 89 deaths have been reported in China, posing great threats to global public health. 90 SARS-CoV-2, severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle 91
East respiratory syndrome coronavirus (MERS-CoV) [1] [2] [3] are subgroups of betacoronavirus 92 genus. As far as we known, the symptoms of COVID-19 range from mild to severe. They can be 93 fever, dry cough, shortness of breath, and in some severe cases, kidney failure or death similar to 94 SARS-CoV infection may occur [4] . However, information regarding to the radiological and 95 clinical features of the pneumonia associated with COVID-19 is still scarce, making it difficult for 96 physicians to distinguish the causative agents without genetic related laboratory analysis. 97
Moreover, reverse transcription-polymerase chain reaction (RT-PCR), the gold standard for a 98 confirmative diagnosis of COVID-19, has obvious limitations, such as certain proportion of false 99 negative results, limited sampling method and shortage of kits. Computed tomography (CT) of the 100 chest is increasingly recognized as strong evidence for early diagnosis, because the changes in J o u r n a l P r e -p r o o f 6 chest imaging sometimes maybe earlier than clinical symptoms. Considering that fewer confirmed 102 cases were included in previous studies [5] , we set up a Jiangsu multi-center study, to collect a 103 considerable larger sample size in this retrospective study. The purpose of the study is to improve 104 the comprehension of the newly-emerged diseases in order to make the diagnosis earlier, by 105 describing the comprehensive chest CT characteristics and clinical features of patients with 106 COVID-19, who were admitted to the designated hospitals in Jiangsu province, China. 107 108 METHODS 109
Patients and clinical data 110
This study was conducted in accordance with the amended Declaration of Helsinki. 111
Independent ethics committees approved the protocol, and written informed consent was obtained 112 from all patients. This was a multi-centered study included 234 inpatients from 13 hospitals during 113 17 days (from January 10th to February 7th 2020) in Jiangsu. All the cases were confirmed with 114 the criteria for SARS-CoV-2 infection established by National Health Commission, which was 115 consistent with one of the following two conditions, based on the pathogenic evidence: 1) positive 116 in real-time fluorescent RT-PCR detection of novel coronavirus nucleic acid in specimens from 117 respiratory tract or blood; 2) virus was highly homologous to the known novel coronavirus in 118 genetic sequencing analyses in specimens from respiratory tract or blood. All the cases underwent 119 an additional microbiological evaluation for ruling out other suspected respiratory infections. 120
Those with a proved additional concurrent acute illness or other preexisting medical conditions 121 severity. Present history, symptoms and signs, blood routine outcomes and therapeutic schedules 124 were also recorded. There were four clinical types according to the severity of disease --mild type, 125 subtle or mild clinical symptoms and no pneumonia found on CT images; common type, fever or 126 respiratory symptoms, etc. and pneumonia observed on CT images; severe type, fulfil any one of 127 the following conditions 1) respiratory distress, respiratory rate (RR) ≥30 times per minute, 2) 128 resting state oxygen saturation (SpO2) ≤93%, or 3) oxygenation index (OI) (calculated by partial 129 pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2)) ≤300mmHg (1mmHg=0.133kPa); 130 critical severe type, fulfil any one of the following conditions 1) respiratory failure and 131 mechanical ventilation needed, 2) shock, 3) combined failure of other organ and ICU monitoring 132 and treatment needed. 133
CT scanning 134
Each subject underwent chest high-resolution CT (HRCT) examination within 24 hours after 135 admission. Inspiratory phase of chest HRCT examination was performed during a single-breath 136 hold at full inspiration. The CT scanner models from the hospitals involved in this multicenter 137 study were listed as following: GE Bright Speed Elite 16, Neusoft 16, SOMATOM Emotion, 138 SOMATOM definition AS, PHLIPS MX-16, Philips 64-row spiral Ingenuity and the UNITED 139 IMAGING Elite 16. The scanning parameters were as following: tube voltage 120kV, tube current 140 110mA, pitch 1.0, rotation time ranging from 0.5s to 0.75s, slice thickness 5mm, with 1mm or 141 1.5mm section thickness for axial, coronal and sagittal reconstructions.
working experience more than 10 years, would make the final decision if there is a divergent 146 opinion between the two attending. 147
Basic CT performances 148
The distribution features and the shape of abnormal attenuation, as well as the involved lung 149 lobes, were recorded. If there were any common accompanying diseases of lung, such as obsolete 150 pulmonary tuberculosis, emphysema, bronchiectasia, tumor and others, they would be recorded. 151
Certain CT signs 152
The following CT performances were judged and recorded as 0 or 1 (0 for none, 1 for yes), 153
including vascular enhancement sign (VES, vascular enlargement inside the lesion resulted from 154 congestion and dilation of small vessels), air bronchus sign, reticular/mosaic sign (defined as a 155 collection of innumerable small linear opacities that, by summation, produced an appearance 156 resembling a net [6] ), bronchial wall thickening, interlobular septal thickening, interlobar fissure 157 displacement, solid nodules, intralesional and/or perilesional bronchiectasis, mediastinal 158 lymphadenopathy, pleural effusion, pleural thickening and pericardial effusion. 159
Quantified evaluation 160
The signs of ground-glass opacity (GGO), consolidation, fibrosis and air trapping and were 161 analyzed quantitatively using a radiologic scoring system ranging from 0-25 points, which was an 162 adaptation of the method previously used to describe idiopathic pulmonary fibrosis and SARS [7] . 163
Each lung lobe was evaluated by 0-5 points, on the basis of the area involved, with score 0 for 164 normal performance, 1 for less than 5% of lung lobe areas involved, 2 for 6%-25%, 3 for 26%-165 50%, 4 for 51%-75%, and 5 for more than 75%. A total score was eventually recorded via the 166 addition of the score of each lobe.
CT stages 168
According to the performances of CT images, the cases were classified into four stages -169 stage I (early stage), stage II (progressive stage), stage III (recovery stage), and stage IV (severe 170 stage). The classification method was mainly according to the following CT performances. Stage I: 171 single or multiple lesions, in irregular, round-like or patchy shapes, generally not involved the 172 whole lung segment, often showed GGO with vascular enlargement. Stage II: more extensive 173 lesions, involved bilateral multiple lobes predominantly in the sub-pleural areas, in irregular, 174 round-like, patchy and "anti-butterfly" shapes, scattered or diffused patches even fusing into large 175 patches with density increased, often with vascular enlargement, reticular sign and bronchial wall 176 thickening, occasionally with less fibrosis and sub-segment atelectasis. Stage III: the lesions 177 absorbed and diminished, the focus can be completely absorbed, with residual fiber stripes. Stage 178 IV: bilateral diffuse lesions, more than half of the lung field involved, even extended to the whole 179 lung and presented as "white lung". 180
Statistical analysis 181
The statistical analyses were performed by Statistical Product and Service Software (SPSS 182 ver. 26.0, Chicago, IL, USA). Descriptive statistics was used in clinical data and some basic 183 information of CT images. Pearson Chi-square test and Fisher exact probability test were used in 184 dichotomous variables (0 or 1) to test the differences of these variables among different CT stages 185 groups. Kruskal-Wallis H test was used to test the group differences of multiple quantitative 186 variables (arterial blood gas (ABG) analysis results and CT scoring). Spearman rank correlation 187 was used to measure the degree of association between the arterial blood gas (ABG) analysis 188 results and CT scoring. A P value less than 0.05 was considered statistically significant and cases and almost 90% patients were classified as common type, as showed in Table-1 
. 201
Fever (72.6%) and cough (64.1%) were main symptoms of patients infected with 202 SARS-CoV-2. There were some other symptoms such as pharyngeal discomfort (15%), fatigue 203 (13.2%), chill (9.8%), muscle ache (9.0%), rhinobyon and snivel (5.6%), diarrhea (3.8%), chest 204 pain (3.4%), chest tightness (5.6%), short of breath (2.1%), difficulty breathing (3%) and nausea 205 and vomiting (2.1%). Most of patients were with normal range of leukocytes count, neutrophils 206 count, lymphocytes count, neutrophil ratio and lymphocyte ratio in the first blood routine 207 examination during hospitalization. The proportion of normal cases were respectively occupied 208 75.1%, 81.7%, 82.6% and 59.7% of all the patients. As to the therapy schedules, each patient was 209 received an antiviral therapy (oral or intravenous antiviral drugs, and inhalation of interferon). infection, methylprednisolone in 34 (14.5%) to suppress the inflammatory response, gamma 212 globulin in 34 (14.5%) to boost immunity, and non-invasive ventilator was used in 11 (4.7%) 213 cases (severe or critical severe patients). According to the performance of chest CT, the patients were divided into stage I-IV, as the 227 cases showed in Figure-1, Figure- The frequency of VES was the highest, but there was no significant difference among the 237 four stage groups, as showed in Table- 2. The frequency of interlobular septal thickening, air 238 bronchus sign and intralesional and/or perilesional bronchiectasis in stage I was significantly 239 lower than that in stage II and stage III (P < 0.008). The frequency of reticular sign, pleural 240 thickening and interlobar fissure displacement was the lowest in stage I (P < 0.008). The 241 frequency of solid nodules in stage IV was significantly higher than that in stage 1 (P < 0.008). 242
The frequency of bronchial wall thickening was lower in stage I than that in stage III and stage IV 243 (P < 0.008). 244
The frequency of pleural effusion, pericardial effusion and mediastinal lymphadenopathy was 245 relatively small. The frequency of pleural effusion was lower in stage I than that in stage III and 246 stage IV, and it was also lower in stage II than that in stage IV (P < 0.008). The frequency of 247 mediastinal lymphadenopathy was lower in stage I than that in stage III (P < 0.008). There was no 248 significant difference of the frequency of pericardial effusion among the four groups. 249
Analysis about clinical and CT quantified data 250

Multiple comparisons among stage I-IV groups 251
As to the group differences of indices from ABG analysis, the SpO2 ((94.70±0.20)%) of 252 patients in stage IV group was significantly lower than that ((97.2±0.91)%) in stage II group, and 253 the OI ((200.25±24.75) mmHg) of patients in stage IV was lower than that ((470.71±38.81) 254 mmHg) in stage I (P < 0.05) (Table-3 ). There were no significant differences of RR and PaO2 among stage I-IV groups (P > 0.05). 256
As to the group differences of CT scores, the CT score of consolidation (5.71±0.42) in stage 257 I was significantly lower than those in other three groups (respectively 7.06±0.49, 7.60±0.66, 258 8.30±1.72), and the CT score of fibrosis (1.98±0.24) in stage I was significantly lower than 259 those in stage II (3.00±0.26) and III (4.12±0.41) (P < 0.05). The air trapping score (0.35±0.10) 260 of inspiratory phase of chest CT was lower in stage I than that in stage IV (1.5±0.76) (P < 0.05) 261 (Table-3 ). The GGO score was higher than consolidation, fibrosis and air trapping scores of all the 262 patients, however, there was no significant difference of GGO score among CT stages (P > 0.05). 263
Correlation analysis 264
There were significant correlations among the ABG analysis indices -PaO2, SpO2 and OI, as 265 well as among the CT scores of GGO, consolidation, fibrosis and air trapping. However, there 266 were no correlations between the ABG analysis indices and CT scores (P > 0.05), except the weak 267 relevance between the fibrosis score and PaO2 (P=0.017, r=0.218) and between fibrosis score and 268 SpO2 (P=0.032, r=0.206), as showed in Table-4 . 269
Discussion 270
The SARS-CoV-2 infection is recognized as a global health hazard. The disease is highly 271 infectious. It is suspected that infection is transmitted by means of large-particle respiratory 272 droplets produced by coughing or touch contamination; hence, good respiratory and hand hygiene 273 is important [8] . 274 A greater number of men (58.1%, 136/234) was found than that of women (41.9%, 98/234), 275 which was similar to previous studies [9] . The reduced susceptibility of females to viral infections 276 might be attributed to the protection from X chromosome and sex hormones, which play an important role in innate and adaptive immunity [10] . Almost 90% patients in present study were 278 classified as common type. Fever and cough were main symptoms. However, some patients 279 As SARS-CoV-2 is highly contagious and with a high incidence, early detection is of great 289 importance. Chest HRCT is a critical screening method for COVID-19 due to its high sensitivity 290
and convenience, although 15 patients with COVID-19 were without abnormal lung changes on 291 initial CT images in present study. Additionally, 6 patients were with pneumonia detected by 292
HRCT, but initial RT-PCR was negative with follow-up test positive. These results suggest that 293 both chest HRCT examination and RT-PCR detection of novel coronavirus nucleic acid have 294 limitations which inevitably lead to false-negative. In the follow-up of the initial negative CT 295 cases, pneumonia will be emerged in some patients, while the initial negative RT-PCR cases will 296 be emerged with positive outcomes after redetection for one time or more than once. It suggests 297 the critical importance to combine the two methods in the early stage of the disease to exclude the There are some typical findings on CT images. The abnormal attenuations are highly 300 frequently located in bilateral multiple lung lobes and distributed in the lower and/or periphery of 301 the lungs, with the shape of irregular, small patches, strip-like, round-like and "anti-butterfly". 302 VES was the most frequent sign, followed by interlobular septal thickening, air bronchus sign, 303
intralesional and/or perilesional bronchiectasis, pleural thickening, solid nodules, reticular/mosaic 304 sign, etc. These CT performances of COVID-19 were similar to previous studies [5] [13] . In addition, 305 a few cases of mediastinal lymph node enlargement, pleural effusion and pericardial effusion were 306 found in present study, which were not reported yet. It may be due to the relatively small sample 307 size of previous study. Furthermore, there are group differences of some CT signs among different 308 CT stages, though GGOs and VES sign were most frequently seen in each CT stages without 309 group differences in patients with COVID-19 pneumonia. In the early stage, interlobular septal 310 thickening, air bronchus sign, intralesional and/or perilesional bronchiectasis and bronchial wall 311 thickening was less seen than that in progressive stage. The reticular sign, pleural thickening and 312 interlobar fissure displacement was not common in early stage. The frequency of pleural effusion, 313 pericardial effusion and mediastinal lymphadenopathy was relatively small. The quantified 314 evaluation of CT images demonstrated that consolidation, fibrosis and air trapping were minor in 315 the early stage. These results suggest that each CT stage has its characteristic CT signs and 316 performances, making it possible to radiologists and physicians to quickly obtained the stage of 317 the pneumonia. 318
As to the ABG results, the SpO2 and OI decreased in patients with severe stage than early or 319 progressed stage, which were in consistence with the alteration of indices in patients with severe 320 or critical severe clinical type. In the severe stage of CT, the bilateral diffuse parenchymal abnormalities were mainly GGO lesions, with consolidation, fibrosis and air trapping. It might 322 demonstrate the severity of pulmonary dysfunction caused by SARS-CoV-2 infection. While the 323 fibrosis score was higher in the recovery stage, which might indicate an improvement of the 324 disease. And a weak positive relevance was found between the fibrosis score and ABG indices 325 (PaO2 and SpO2), that was, a patient with higher fibrosis score tended to have better ABG results, 326
suggesting that fibrosis score may be a potential index in the prognosis of the disease. J o u r n a l P r e -p r o o f Table-3 The group differences of SpO2, OI, and CT scores of consolidation, fibrosis and air trapping   I-II  I-III  I-IV  II-III  II-IV  III- 
